Literature DB >> 21463074

Interaction effects of age and contingency management treatments in cocaine-dependent outpatients.

Lindsay M Weiss1, Nancy M Petry.   

Abstract

As the American population ages, older adults are accounting for a larger percentage of the drug-abusing population, but little attention has been given to this age group especially in regards to evaluating responsivity to different treatment modalities. Contingency management (CM) is a highly effective behavioral treatment that provides positive tangible reinforcers for objective evidence of behavior change. The purpose of this study was to examine main and interactive effects of age on outcomes in cocaine-dependent patients receiving CM with standard care (SC) or SC alone. Patients (N = 393) participating in 1 of 3 randomized trials of CM for cocaine dependence were divided into young, middle, and older age cohorts. Baseline characteristics and outcomes were compared across the age groups. The oldest age group had more medical problems than the youngest and middle age groups but had fewer legal difficulties and psychiatric symptoms. The oldest age group remained in treatment significantly longer than the other age groups, regardless of the type of treatment received. Although all age groups benefited from CM in terms of retention and longest duration of abstinence achieved, a significant age by treatment interaction effect emerged, with the older cohort improving relatively less from CM than the younger age groups. These findings demonstrate that age may play a role in moderating intervention outcomes, and tailoring CM to the needs of older and middle-aged substance abusers may be important for improving outcomes in this growing population.

Entities:  

Mesh:

Year:  2011        PMID: 21463074      PMCID: PMC3121106          DOI: 10.1037/a0023031

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  41 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

Review 2.  Empirically supported individual and group psychological treatments for adult mental disorders.

Authors:  R J DeRubeis; P Crits-Christoph
Journal:  J Consult Clin Psychol       Date:  1998-02

Review 3.  Treatment approaches for older problem drinkers.

Authors:  L Schonfeld; L W Dupree
Journal:  Int J Addict       Date:  1995 Nov-Dec

4.  Reliability of individual diagnostic criterion items for psychoactive substance dependence and the impact on diagnosis.

Authors:  K K Bucholz; V M Hesselbrock; J J Shayka; J I Nurnberger; M A Schuckit; I Schmidt; T Reich
Journal:  J Stud Alcohol       Date:  1995-09

5.  Ensuring balanced distribution of prognostic factors in treatment outcome research.

Authors:  R L Stout; P W Wirtz; J P Carbonari; F K Del Boca
Journal:  J Stud Alcohol Suppl       Date:  1994-12

6.  Diabetic ketoacidosis associated with cocaine use.

Authors:  E A Warner; G S Greene; M S Buchsbaum; D S Cooper; B E Robinson
Journal:  Arch Intern Med       Date:  1998-09-14

7.  Patterns of diagnosis and treatment among late-middle-aged and older substance abuse patients.

Authors:  R H Moos; J R Mertens; P L Brennan
Journal:  J Stud Alcohol       Date:  1993-07

8.  Age group differences in response to treatment for problematic alcohol use.

Authors:  C Rice; R Longabaugh; M Beattie; N Noel
Journal:  Addiction       Date:  1993-10       Impact factor: 6.526

9.  Five-year alcohol and drug treatment outcomes of older adults versus middle-aged and younger adults in a managed care program.

Authors:  Derek D Satre; Jennifer R Mertens; Patricia A Areán; Constance Weisner
Journal:  Addiction       Date:  2004-10       Impact factor: 6.526

10.  The risk for mild kidney function decline associated with illicit drug use among hypertensive men.

Authors:  Suma Vupputuri; Vecihi Batuman; Paul Muntner; Lydia A Bazzano; John J Lefante; Paul K Whelton; Jiang He
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

View more
  8 in total

Review 1.  Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?

Authors:  Nancy M Petry; Sheila M Alessi; Todd A Olmstead; Carla J Rash; Kristyn Zajac
Journal:  Psychol Addict Behav       Date:  2017-06-22

2.  The subjective effects of cocaine: relationship to years of cocaine use and current age.

Authors:  Raj K Kalapatapu; Gillinder Bedi; Margaret Haney; Suzette M Evans; Eric Rubin; Richard W Foltin
Journal:  Am J Drug Alcohol Abuse       Date:  2012-07-19       Impact factor: 3.829

3.  Considerations for Implementing Contingency Management in Substance Abuse Treatment Clinics: The Veterans Affairs Initiative as a Model.

Authors:  Carla J Rash; Dominick DePhilippis
Journal:  Perspect Behav Sci       Date:  2019-06-26

4.  Older methadone patients achieve greater durations of cocaine abstinence with contingency management than younger patients.

Authors:  Lindsay Weiss; Nancy M Petry
Journal:  Am J Addict       Date:  2013-02-01

5.  Initial abstinence status and contingency management treatment outcomes: does race matter?

Authors:  LaTrice Montgomery; Kathleen M Carroll; Nancy M Petry
Journal:  J Consult Clin Psychol       Date:  2015-03-23

6.  Relationship of age to impulsivity and decision making: a baseline secondary analysis of a behavioral treatment study in stimulant use disorders.

Authors:  Raj K Kalapatapu; Daniel F Lewis; Sophia Vinogradov; Steven L Batki; Theresa Winhusen
Journal:  J Addict Dis       Date:  2013

7.  Interest and preferences for contingency management design among addiction treatment clientele.

Authors:  Bryan Hartzler; Sharon Garrett
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-08       Impact factor: 3.829

Review 8.  Cocaine Use Disorder (CUD): Current Clinical Perspectives.

Authors:  Elizabeth K C Schwartz; Noah R Wolkowicz; Joao P De Aquino; R Ross MacLean; Mehmet Sofuoglu
Journal:  Subst Abuse Rehabil       Date:  2022-09-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.